Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 14Recruiting 6Unknown 4Active not recruiting 3Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 39Head & Neck 28Gastrointestinal 25Gynecologic 10Genitourinary 5Other solid neoplasm 4Breast 4Tumor-Agnostic 1NET 1Lymphoid 1Endocrine 1Dermatologic 1CNS 1

Conditions

Neuroendocrine Tumors 1

Interventions

Observation 2Interviews as Topic 2Fluorouracil 2Carboplatin 2Adrenalectomy 2zimberelimab 1trametinib 1lutetium Lu 177 dotatate 1dabrafenib 1cemiplimab 1apatinib 1anlotinib 1Watchful Waiting 1Thyroxine 1Surveys and Questionnaires 1Standard of Care 1Radiomics 1Radiation 1Positron Emission Tomography Computed Tomography 1Mitoxantrone 1Leucovorin 1Irinotecan 1Injections 1IFL protocol 1Etoposide 1Engineering 1Endoscopic Mucosal Resection 1Decision Support Techniques 1Counseling 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Cisplatin × Endocrine × Clear all
NCT06485739 2024-07-03

Irinotecan Liposomes for the Treatment of Neuroendocrine Carcinoma

First Affiliated Hospital Xi'an Jiaotong University

Phase 4 Not yet recruiting
20 enrolled
EndocrineNET

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡